Upload
bindu-sharma
View
212
Download
0
Embed Size (px)
Citation preview
8/22/2019 Origiin Newsletter August 2013
1/8
All rights reserved (c) Origiin IP Solutions LLP 2013
x
his issue
tent alerts...... ...P.1
News Bulletin .........................P.3
ws from IPO ......................................P.4
onthly IPO Statistics .. ..P.5
eresting patent of the month ..............P.6
tional award: TIFAC ...P.7
dian Patent Agent Exam study material
ition 3.0 ..P.8
A monthly
Newsletter
on issues
relating to
Intellectual
Property
Rights
S U E ( V o l u m e )
MONTH
August
YEAR
2013
7 (3) Origiin Newsletter
Patent alerts: To stay ahead of the competition
As we know that
innovation is the
key to sustainable
growth for any business today and
patents play a vital role by securing
innovations and obtaining competitive edge
in the market. Patent filing is increasing
globally and according to World Intellectual
Property Organisation (WIPO) report,
International patent filings increased by 6.6
percent in 2012 from the previous year,
with China, Japan and South Korea posting
double-digit growth. It shows the
importance of building strong, intangible
asset portfolios, even in times of crisis,
because you need it for a recovery, Francis
Gurry, head of the UN agency said.
Patents are excellent source of technical
information, primarily for the reason that
inventions are not only disclosed
systematically in the patent specification
Contact us
#35, First FloorFirst Main, Vysya Bank Colony
BTM 2nd Stage
Bangalore-560076
Email: [email protected]
hats new in this issue?
onthly statistics from Indian
tent Office July 2013
ebsites
w.origiin.com
w.origiinipa.com
ogsiinipae.blogspot.com
entorshub.blogspot.com
torsta Kalia
ira A
But also the best mode is disclosed to
meet statutory requirements in most of
the jurisdiction. Therefore, the patent
databases contain valuable information to
detect technology evolution.
Staying ahead of your competitors in the
world where innovation is happening in
every area of technology is not easy. In
order to improve quality of innovation,
avoid duplication of work, filing quality
patents and giving right direction to R&D,
it is essential for the companies to be
updated with latest inventions for which
patent applications are being
filed/published/granted/expired.
However, keeping track of the kind and
number of patent applications published,
granted, abandoned or expired is a big
challenge today. On one hand, knowing
latest happenings in the area of patents
helps business in multiple ways, on the
other hand, with growing data &
increasing number of patent filing,
extracting desirable
http://phys.org/tags/un+agency/http://www.origiin.com/http://www.origiin.com/http://www.origiinipa.com/http://www.origiinipa.com/http://origiinipae.blogspot.com/http://origiinipae.blogspot.com/http://inventorshub.blogspot.com/http://inventorshub.blogspot.com/http://inventorshub.blogspot.com/http://origiinipae.blogspot.com/http://www.origiinipa.com/http://www.origiin.com/http://phys.org/tags/un+agency/8/22/2019 Origiin Newsletter August 2013
2/8
All rights reserved (c) Origiin IP Solutions LLP 2013
information is extremely tough.
Generating periodic (weekly, monthly or half yearly)
patent alerts is one of the most effective tools to track
the latest happenings in the area of patents.
Published/granted and even abandoned/expired patents
can be monitored on regular basis in the technical area
of interest to get valuable information on:
Generating periodic (weekly, monthly or
half yearly) patent alerts is one of the most
effective tools to track the latest
happenings in the area of patents.
A. New products/processes for which patentapplications have been filed and build up own
products to ensure that the same invention is
not replicated and also to assess likelihood of
patent infringement. In addition to this, since the
patents technically disclose the invention,thorough review of the same might be extremely
useful to assess chances of getting patent for
your core technologies or new idea by knowing
novelty, non-obviousness and industrial
applicability of the invention.
B. By knowing published applications, one mightwant to oppose the applications, which may not
be subject matter of a patent or grant of which
might affect the business adversely, though
there are several other reasons to oppose a
patent application or a grant patent.
C. New markets or new technologies that yourcompetitors are focussing at. This might give you
overview of the kind of products they are
planning to launch in given markets.
Patent watch can be done primarily in two ways:
Technical Patent Watch: Here you may list out core
technology (ies) of interest and monitor newly published
patent applications in a technical area of interest as soon
as they are published. One may also monitor latest
prosecution status of pending patent applications. This
way it will be easier to keep in touch with latest
happenings and one may also come across interesting
patents that may be used and implemented to add value
to existing products or technologies.
Such patents may be licensed or if they are not filed in
the jurisdiction of interest or they dont have a chance to
be filed in the jurisdiction of interest, it may be used
without any fear of infringement. However, it is highly
recommended to take opinion of an expert on the legal
status of such patent (s) before implementing it.
Competitor Patent Watch: Knowing patent portfolio and
watching patent activity of the competitors may be of
great business value. Competitor companies may be
listed out and their newly published patent applications
may be monitored on periodic basis. However, one may
also monitor latest prosecution status of pending patent
applications or latest legal status/continuation
applications of granted patents of competitor companies.
This information may prove to be a game changing
strategy for any company.
Staying ahead of your competitors is critical for
sustainability today. With increasing focus on innovation,
it becomes important to know about the recent trends in
the area of patent filings. It is not only interesting to
watch what your competitors are doing or the latest
technologies for which patents are being filed in given
jurisdiction, but also, it gives you platform which you can
use to fine tune your existing products and assess
chances of infringement.
2
8/22/2019 Origiin Newsletter August 2013
3/8
All rights reserved (c) Origiin IP Solutions LLP 2013
9. Ireland (9)10.United States of America (10)
The Global Innovation Index (GII) is recognition of the key
role that innovation serves as a driver of economic growth
and prosperity. It is also an acknowledgement of the need
for a broad horizontal vision of innovation that is
applicable to both developed and emerging economies,
with the inclusion of indicators that go beyond the
traditional measures of innovation (such as the level of
research and development in a given country). The GII is a
valuable benchmarking tool to facilitate public-private
dialogue, whereby policymakers, business leaders and
other stakeholders can evaluate progress on a continual
basis.
New rice variety: A bliss for diabetic patients
Dr Mohan's Group of Institutions launched Jeevan Dharini,
a brand of white rice and rice rava, on 17th July 2013 to
address a dietary challenge faced by most Indians,
especially vegetarians; the food they consume does not
contain enough fibre.
Dr V Mohan, director, Dr Mohans Group of Institutions,
said, Dr Mohans Jeevan Dharini Rice is an exceptional
high-fibre rice variety and the first of its kind in the world.
It was developed by employing intensive classical plant-
breeding and bio-chemical screening approaches. The
chief guest of the launch Prof MS Swaminathan, Founder
Chairman and Chief Mentor, MS Swaminathan Research
Foundation, Chennai launched the Jeevan Dharini Rice.
This variety of rice has been developed after years of
research and researching over 200 varieties of rice.
IP NEWS BULLETINBoston University sues Apple over 1997 patent
Boston University wants a ban on the sale of a wide
variety of Apple products and companys profits from the
last few years, all because of a patent filed for in 1995.
Boston University is not only seeking an injunction
banning the sale of a wide range of Apple products, but is
also asking for an accounting of Apples profits. The
school wants Apple to hand over its earnings from the
last few years. University want a federal court to ban the
sale of a wide range of Apple products, including the
iPhone 5, the iPad and the MacBook Air, because they
allegedly infringe a patent issued to one of its professors
in 1997.
IPAB revokes GSK patent on breast cancer drug Tykerb
The Intellectual Property Appellate Board (IPAB) has
revoked a patent granted to GlaxoSmithKline Plc for its
breast cancer drug Tykerb. India's latest move is a blow
for GSK, which had cut prices of Tykerb by one third in
the country as part of a flexible pricing programme
designed to make key drugs more affordable in certain
emerging markets. Patent was revoked on the grounds of
obviousness, insufficiency of description, non-
patentability and non-disclosure under Section 8 of the
Patents Act, 1970.
Global Innovation Index 2013
The sixth edition (2013), of the GII is co-published by
Cornell University and the World Intellectual Property
Organization (WIPO). Top Ten 2013 ranking is as below:
1. Switzerland (Number 1 in 2012)2. Sweden (2)3. Singapore (3)4. Finland (4)5. United Kingdom (5)6. Netherlands (6)7. Denmark (7)8. Hong Kong (China) (8)
3
http://www.globalinnovationindex.org/http://gigaom.com/2013/07/03/boston-university-sues-apple-over-1997-patent-asks-for-ban-on-iphone-sales/http://www.business-standard.com/search?type=news&q=Ipabhttp://www.business-standard.com/search?type=news&q=Patenthttp://www.business-standard.com/search?type=news&q=Breast+Cancer+Drughttp://www.business-standard.com/search?type=news&q=Gskhttp://www.cornell.edu/http://www.cornell.edu/http://www.business-standard.com/search?type=news&q=Gskhttp://www.business-standard.com/search?type=news&q=Breast+Cancer+Drughttp://www.business-standard.com/search?type=news&q=Patenthttp://www.business-standard.com/search?type=news&q=Ipabhttp://gigaom.com/2013/07/03/boston-university-sues-apple-over-1997-patent-asks-for-ban-on-iphone-sales/http://www.globalinnovationindex.org/8/22/2019 Origiin Newsletter August 2013
4/8
All rights reserved (c) Origiin IP Solutions LLP 2013
4
IMPORTANT NEWS FROM INDIAN PATENT
OFFICE
Madrid protocol
The Madrid Protocol came into force in India on 8th July
2013, three months after the country signed the treaty.
India became the protocols 90th member in April this
year, paving way for local businesses to protect their
marks in multiple jurisdictions by filing one application
with one set of fees. India is the 14th of the G-20
economies to accede to the Madrid Protocol. Madrid
Protocol provides an efficient and cost-effective way of
obtaining trademark protection. At the time, World
Intellectual Property Organization (WIPO) director
general Francis Gurry said the move was a major
milestone and gives brand owners around the world
the ability to extend their protection to the important
Indian market.
The advantages of Indian accession to Protocol are:
(a) Centralised trade mark application process for
designated Protocol members through one basic
application in one Protocol country with one set of fees;
(b) Cost effective method of trade mark protection in
many territories;
(c) Administrative convenience of handling of renewal
and subsequent ownership changes;
(d) Protection extended to Protocol countries which may
have been ignored or left out and addition of new
countries to the international registration after these
new countries join the Protocol.
Indias participation in the Madrid system gives brand
owners around the world the ability to extend their
protection to the important Indian market, through a
single, simplified and cost-effective procedure.
Samsung seeks re-trial over $1 billion Apple lawsuit
Samsung Electronics has requested a re-trial in part of a
patent infringement case brought by rival Apple which
saw it levied with a $1 billion fine. Samsung, which was
deemed to have infringed seven Apple patents, has asked
the US District Court for the Northern District of Californiafor a retrial of the damages ruling. Samsungs request
covers a patent for list scrolling and document translation
on a touch screen.
UCB files cases against Ranbaxy, Aurobindo, Glenmark
etc
UCB, a global biopharma company, alongwith others has
filed separate cases against as many as 15 drug makers,
including India's Ranbaxy, Aurobindo, Zydus, Sun Pharma,
Glenmark and Alembic pharmaceuticals for allegedly
infringing its patented drug Vimpat. For the 12 months
ending March 31, 2013, Vimpat had US sales of
approximately $338 million, according to IMS Health.
According to a petition filed by UCB, Inc, UCB Pharma
GMBH, Research Corporation Technologies, Inc and Harris
FRC Corporation the patent its drug Lacosamide Tablets,
50 mg, 100 mg, 150 mg and 200 mg would expire on
March 17, 2022. The drug is approved as an adjunctive
therapy to treat partial-onset seizures of people
diagnosed with epilepsy aged 17 years and older.
The patent infringement petition was filed against
Aurobindo Pharma Ltd, Accord Healthcare Inc, Alembic
Pharmaceuticals Ltd, Amneal Pharmaceuticals, Apotex
Corp, Breckenridge Pharmaceutical Inc, Glenmark
Generics , Hetero USA Inc Mylan Pharmaceuticals Inc.
The petitioners requested the court to issue a permanent
injunction and enjoining the respondents from engaging in
the commercial manufacture, use offer to sell or import
until the expiration of the patent or any later date of
exclusivity to which the petitioners are entitled.
8/22/2019 Origiin Newsletter August 2013
5/8
All rights reserved (c) Origiin IP Solutions LLP 2013
MONTHLY STATISTICS FROM INDIAN PATENT OFFICE: JULY 2013
Top 10 Patent Grantees in July 2013
In the month of July 2013, nearly 217 Patent have been granted by the Indian Patent office.
Samsung India Software Operations Private Limited get maximum number of patents, followed by Continental
Automotive Gmbh, Council of Scientific & Industrial Research, GM Global Technology Operations Inc, Bharat
Heavy Electricals Limited, Dow Global Technologies, LLC, DSM IP Assets B.V, International Business Machines
Corporation, Ion Exchange (INDIA) Limited etc.
Branch wise distribution of granted patents
Comparison of granted patents among IPO branches indicates that maximum number of patents have been
granted by Delhi branch, followed by Chennai, Kolkata and Mumbai. However, number of PCT national phase
applications is quite high compared to non-PCT national phase applications in Delhi, Chennai and Kolkata branch
office and Mumbai branch office has number of non-PCT national phase applications is high as compared to PCT
national phase applications.
02468
101214
Top 10 Patent Grantees July 2013
Series1
0
10
20
30
40
50
60
Delhi Chennai Kolkata Mumbai
Branch wise distribution of Granted Patents
PCT-NP
Non PCT-NP
Patents
Granted
Patent Office Branches
8/22/2019 Origiin Newsletter August 2013
6/8
All rights reserved (c) Origiin IP Solutions LLP 2013
IPC distribution of granted patents
Segregation of patents granted in the month of July 2013 on the basis of basic International Patent Classification
reveal that maximum patents have been granted in Class C (Chemistry; Metallurgy), followed by Class H
(Electricity), Class A (Human Necessities), Class G (Physics), Class B (Performing; Operations; Transporting) etc.
INTERESTING PATENT OF THE MONTH
Method of exercising a cat
Publication number: US5443036 A
Application number: US 08/144,473
Publication date: 22 Aug 1995
Filing date: 2 Nov 1993
Priority date: 2 Nov 1993
Inventors:Martin H. Abbott, Kevin T. Amiss
Original Assignee:Abbott; Martin H., Amiss; Kevin T
Abstract: A method for inducing cats to exercise consists of directing a beam of invisible light produced by a
hand-held laser apparatus onto the floor or wall or other opaque surface in the vicinity of the cat, then moving
the laser so as to cause the bright pattern of light to move in an irregular way fascinating to cats, and to any
other animal with a chase instinct.
Main claim
1. A method of inducing aerobic exercise in an unrestrained cat comprising the steps:
a) directing an intense coherent beam of invisible light produced by a hand-held laser apparatus to produce a
bright highly-focused pattern of light at the intersection of the beam and an opaque surface, said pattern being
of visual interest to a cat; and
(b) selectively redirecting said beam out of the cat's immediate reach to induce said cat to run and chase said
beam and pattern of light around an exercise area
0102030405060708090
IPC CODE
Count of IPC CODE
http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Martin+H.+Abbott%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Martin+H.+Abbott%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Kevin+T.+Amiss%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Abbott%3B+Martin+H.%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Abbott%3B+Martin+H.%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Amiss%3B+Kevin+T.%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Amiss%3B+Kevin+T.%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Abbott%3B+Martin+H.%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Kevin+T.+Amiss%22http://www.google.co.in/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Martin+H.+Abbott%228/22/2019 Origiin Newsletter August 2013
7/8
All rights reserved (c) Origiin IP Solutions LLP 2013
NATIONAL AWARD: COMMERCIALIZABLE PATENTS YEAR 2013-14
Department of science and technology, Govt. of India, has announced National award for Commercializable Patents
for the year 2013-2014. Technology Refinement and Marketing Programme (TREMAP) is a unique programme of
Technology Information, Forecasting and Assessment Council (TIFAC), which supports Indian innovations towards
making them investment ready. The awards were first introduced two years ago and in the year 2012, the award
was granted to eight patent holders
The important features are as follows:
Award to individual patent holders/micro/small and medium enterprises (MSMEs) to promotecommercialization of patented technologies.
Award will carry sum of Rs. 5.00 lakh + a certificate + incentive of Rs. 5.00 lakh on commercialization of theawarded patents.
Selection procedure Preliminary screening of application. Filtering of applications (by panel of technical experts) High Level Selection by selection committee (Innovators Presentation)
Eligibility Criteria Applicant(s) must be an Indian National or MSME. Indian patent must have been granted for the technology / product / process in the name of
individual(s) or MSME.
The date of grant of patent should be on or after 1st January 2010. The technology should have good commercial application value. The model / prototype of the technology should be ready and in well working condition.
Not Eligible The patents which are already commercialized/ transferred / licensed. Patents / innovations related to herbal, healthcare, pharmaceutical, biotechnology etc. requiring
long term trials / testing and pure software products / technologies and patents relating to strategic
sector (space, nuclear, arms and armaments etc.)
Timelines Release of Advertisement by TIFAC: 22nd June 2013. Last Date of Receipt of Applications: 14th August 2013. First level of screening: 31st August 2013. Second level of screening: 30th October 2013. Third level of screening: 31st December 2013. Award Function: 10th February 2014 (TIFAC Day).
For further details please visithttp://www.tifac.org.in
http://www.tifac.org.in/http://www.tifac.org.in/http://www.tifac.org.in/http://www.tifac.org.in/8/22/2019 Origiin Newsletter August 2013
8/8
IPAE Study material:Edition 3.0
After conducting four successful batches for Indian Patent Agent Examination training, Origiin IP Academy is shortlylaunching 3rd Edition of study material for Indian Patent Agent Examination (IPAE) preparation.
The details of study material for patent agent examination are as below:
A. What we offer: Study material to assist you with preparation for Indian Patent Agent Examination.B. What does study material comprise of: The study material has three modules
o First Module: Interpretation of each and every section/rule of Indian Patents Act/Rules andexplanation with illustration, case-study and examples.
o Second Module: Important conventions, PCT, Patent drafting, License agreement and tips for viva.o Third Module: Solutions of all previous year question papers from year 2004 to 2013.
C. Additional support: You get Assignments and Dictionary on Indian Patent Law absolutely FREE!!! Mock tests,sample practice papers are also provided.
D. Cost: The entire course costs only 16,000 INR (includes all the three modules, assignments and Dictionary onIndian Patent Law).
E. Eligibility: Candidate must be a citizen of India; completed the age of 21 years; and must have obtained adegree in Science, Engineering or Technology from any University established under the law for the time
being in force in the territory of India or possesses such other equivalent qualifications as the Central
Government may specify.
F. How to register: Download registration form from http://www.origiinipa.com and send it to us to registeryourself. For details, write us [email protected] or [email protected]
Our other certificate courses:
1. Certificate course: Patentability search2. Certificate course: Clearance search3. Certificate course: Technology Landscape analysis4. Certificate course: Invalidation/validation search5. Certificate course: IP audit and commercialization (coming soon)
Disclaimer: The purpose of this Origiin newsletter is to provide general information to the readers on IPR & is not intended as a
substitute for professional consultation and advice on a particular subject matter. For specific issues, kindly seek legal assistance.
The IP News and IPO statistics have been compiled from the information available in public domains and Origiin is not as such,
responsible for any error, omission, and mistake or misfiled particulars contained or omitted from the said records. Column in the
Newsletter is based on authors experience in the area of IPR and views reflected in column are purely of the authors . Please mail
us [email protected] yourvaluablefeedback/comments.
http://www.origiinipa.com/mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]://www.origiinipa.com/